Activity of bortezomib administered once every 3 weeks for treatment of relapsed multiple myeloma

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1033-1035
Number of pages3
JournalLeukemia and Lymphoma
Volume50
Issue number6
DOIs
StatePublished - 2009

Fingerprint

Drug Administration Schedule
Boronic Acids
Pyrazines
Protease Inhibitors
Multiple Myeloma
Recurrence
Bortezomib

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

@article{62b3332d09204253979ca4b5f70f602f,
title = "Activity of bortezomib administered once every 3 weeks for treatment of relapsed multiple myeloma",
author = "Ibrahim Sadek and Angela Dispenzieri and Morie Gertz and Kumar, {Shaji K}",
year = "2009",
doi = "10.1080/10428190902919218",
language = "English (US)",
volume = "50",
pages = "1033--1035",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Activity of bortezomib administered once every 3 weeks for treatment of relapsed multiple myeloma

AU - Sadek, Ibrahim

AU - Dispenzieri, Angela

AU - Gertz, Morie

AU - Kumar, Shaji K

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=68449093121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68449093121&partnerID=8YFLogxK

U2 - 10.1080/10428190902919218

DO - 10.1080/10428190902919218

M3 - Article

VL - 50

SP - 1033

EP - 1035

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 6

ER -